231 related articles for article (PubMed ID: 35006504)
21. Endovascular treatment of delayed arterial hemorrhage after radical operation for hilar cholangiocarcinoma.
Wang XD; Ge NJ; He CJ; Zhu JJ; Xu W; Yang YF
Hepatobiliary Pancreat Dis Int; 2023 Aug; 22(4):403-405. PubMed ID: 36858893
[No Abstract] [Full Text] [Related]
22. Hepatopancreatoduodenectomy with simultaneous resection of the portal vein and hepatic artery: Ultimate superextended surgery for advanced perihilar cholangiocarcinoma.
Nagino M
J Hepatobiliary Pancreat Sci; 2022 Jun; 29(6):597-599. PubMed ID: 34935293
[No Abstract] [Full Text] [Related]
23. ASO Author Reflections: Laparoscopic Surgery of Perihilar Cholangiocarcinoma Between Oncologic Adequacy and Technical Challenges.
Ratti F; Aldrighetti L
Ann Surg Oncol; 2020 Dec; 27(13):5193-5194. PubMed ID: 32458328
[No Abstract] [Full Text] [Related]
24. Cholangioscopy-assisted partial stent-in-stent method useful for bilateral biliary drainage of hilar cholangiocarcinoma.
Kazumori H; Ohno Y; Kawashima K
Endoscopy; 2023 Dec; 55(S 01):E1264-E1265. PubMed ID: 38128591
[No Abstract] [Full Text] [Related]
25. ASO Author Reflections: Monitoring the Risk of Recurrence After Curative-Intent Liver Resection for Intrahepatic Cholangiocarcinoma by Applying Hazard Function Analysis.
Alaimo L; Moazzam Z; Pawlik TM
Ann Surg Oncol; 2023 Mar; 30(3):1350-1351. PubMed ID: 36006495
[No Abstract] [Full Text] [Related]
26. ASO Author Reflections: Left Trisectionectomy for Bismuth-Corlette Type IV Perihilar Cholangiocarcinoma with Left-Sided Predominance.
Hosokawa I; Shimizu H
Ann Surg Oncol; 2020 Jul; 27(7):2387-2388. PubMed ID: 32323086
[No Abstract] [Full Text] [Related]
27. ASO Author Reflections: Essential to Reduce Adverse Outcomes in Perihilar Cholangiocarcinoma Surgery-Portal Vein Embolization.
Olthof PB; van Gulik TM
Ann Surg Oncol; 2020 Jul; 27(7):2319-2320. PubMed ID: 32152772
[No Abstract] [Full Text] [Related]
28. ASO Author Reflections: Incorporating Circulating Tumor DNA in Perioperative Management of Intrahepatic Cholangiocarcinoma.
Choi WJ; Sapisochin G; O'Kane GM
Ann Surg Oncol; 2023 Jun; 30(6):3864-3865. PubMed ID: 36752965
[No Abstract] [Full Text] [Related]
29. ASO Author Reflections: Intrahepatic Cholangiocarcinoma: Downstaging Strategies Open the Gate to Surgery and Cure.
Boudjema K; Edeline J
Ann Surg Oncol; 2020 Oct; 27(10):3738-3739. PubMed ID: 32314152
[No Abstract] [Full Text] [Related]
30. Robotic Left Hepatectomy with en bloc Caudatectomy and Multiple Biliary Anastomosis for Perihilar Cholangiocarcinoma.
Di Benedetto F; Magistri P; Catellani B; Guerrini GP; Di Sandro S
Ann Surg Oncol; 2023 May; 30(5):2832-2833. PubMed ID: 36790730
[No Abstract] [Full Text] [Related]
31. [Benign hilar bile duct stricture resected as perihilar cholangiocarcinoma].
Nagino M; Ebata T; Otsuka S
Nihon Shokakibyo Gakkai Zasshi; 2020; 117(8):679-688. PubMed ID: 32779585
[No Abstract] [Full Text] [Related]
32. ASO Author Reflections: Can Invasive Tumor Thickness Stratify the Postoperative Prognosis of Perihilar Cholangiocarcinoma?
Nakanishi Y; Oba M; Hirano S
Ann Surg Oncol; 2021 Apr; 28(4):2010-2011. PubMed ID: 32935267
[No Abstract] [Full Text] [Related]
33. ASO Author Reflections: Hepatobiliary Surgeons are Spurred to Implement Totally Minimally Invasive Techniques for Perihilar Cholangiocarcinoma Surgery.
Sucher R; Seehofer D
Ann Surg Oncol; 2021 Apr; 28(4):2035-2036. PubMed ID: 33001301
[No Abstract] [Full Text] [Related]
34. ASO Author Reflections: Disparate Outcomes in Stage II Intrahepatic Cholangiocarcinoma: A Case for Upstaging Multifocal Tumors.
Turner KM; Wilson GC
Ann Surg Oncol; 2022 Aug; 29(8):5103-5104. PubMed ID: 35482267
[No Abstract] [Full Text] [Related]
35. Liver transplantation for intrahepatic and perihilar cholangiocarcinoma: Current and future.
Zheng SS; Yang Z; Wu YC
Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):101-102. PubMed ID: 32165068
[No Abstract] [Full Text] [Related]
36. ASO Author Reflections: Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status in Patients with Intrahepatic Cholangiocarcinoma.
Endo Y; Moazzam Z; Lima HA; Pawlik TM
Ann Surg Oncol; 2023 Apr; 30(4):2033-2034. PubMed ID: 36396871
[No Abstract] [Full Text] [Related]
37. ASO Author Reflections: Minimally Invasive Approach and Oncologic Benefit in Intrahepatic Cholangiocarcinoma (iCCA) With Risk of Very Early Recurrence: Is it Time to Consider Technique as a Key Element of Onco-Surgical Strategy?
Ratti F; Maina C; Aldrighetti LAM
Ann Surg Oncol; 2024 Apr; 31(4):2602-2603. PubMed ID: 38329658
[No Abstract] [Full Text] [Related]
38. ASO Author Reflections: Accuracy of Preoperative Staging and Downstaging After Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma.
Alaimo L; Lima HA; Moazzam Z; Pawlik TM
Ann Surg Oncol; 2023 Aug; 30(8):4809-4810. PubMed ID: 37046130
[No Abstract] [Full Text] [Related]
39. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
40. ASO Author Reflections: Identification of Intrahepatic Cholangiocarcinoma Clusters Using Machine Learning Techniques: Should Patients be Treated Differently?
Tsilimigras DI; Paredes AZ; Pawlik TM
Ann Surg Oncol; 2020 Dec; 27(13):5233-5234. PubMed ID: 32591955
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
